Armistice Capital »

Ernexa Therapeutics shares owned by Armistice Capital

Quarter-by-quarter ownership of Ernexa Therapeutics shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Ernexa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ernexa Therapeutics held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ernexa Therapeutics by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $112k 4.0M 0.03

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Ernexa Therapeutics

Armistice Capital
Warberg Asset Management
Clear Street Group

View all funds holding Ernexa Therapeutics